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Abstract 
 
Background. Fibrin deposition within glomeruli is commonly seen in kidney biopsy specimens, 
suggesting enhanced coagulant activity. Tissue factor (TF) is a coagulation factor which is also 
related to various biological effects, and TF is upregulated by hypoxia in cancer cells. Recently, 
hypoxic podocyte injury has been proposed, therefore, we investigated TF expression in hypoxia. 
Methods. Conditionally immortalized human podocytes were differenciated and treated under 
hypoxic or normoxic conditions. mRNA expressions of TF and tissue factor pathway inhibitor (TFPI) 
were analyzed by quantitative RT-PCR. Protein levels of TF and TFPI were tested by enzyme-linked 
immunosorbent assay. We employed small interfering RNA (siRNA) to temporary knockdown early 
growth response protein 1 (Egr-1), hypoxia-inducible factor-1α (HIF-1α) and TF. The expression of 
CD2-associated protein (CD2AP) mRNA and phalloidin staining was examined to assess podocyte 
injury. 
Results. Hypoxia increased mRNA expression of TF (6h: 2.3±0.05 fold, p<0.001, 24h: 5.6±2.4 fold, 
p<0.05) and suppressed TFPI (6h: 0.54±0.04 fold, p<0.05, 24h: 0.24±0.06 fold, p<0.001) compared 
with normoxia. Similarly, protein levels of TF were increased and TFPI were decreased. Egr-1 siRNA 
did not change TF mRNA expression. Pyrrolidine dithiocarbamate (PDTC), a nuclear factor kappa B 
(NF-κB) inhibitor significantly reduced hypoxia induced TF expression, and HIF-1α knockdown 
further increased TF. Hypoxia resulted in the decreased CD2AP and actin reorganization in podocytes, 
and these changes were attenuated by TF siRNA. 
Conclusion. Hypoxia increased the expression of TF in human podocytes NF-κB dependently. TF 
may have a critical role in the hypoxic podocyte injury.  
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Introduction 
Fibrin deposition within the glomeruli is commonly seen in kidney biopsy specimens, particularly 
in crescentic glomerulonephritis, chronic glomerulonephritis, diabetic nephropathy, and malignant 
hypertension. Thus, enhanced coagulant activity is suggested in glomerular injury. 
Tissue factor (TF), also known as coagulation factor III or CD142, is a 46-kDa transmembrane 
glycoprotein. As well as being an initiator of extrinsic blood coagulation cascade, TF play an 
important role in numerous physiologic and pathologic conditions such as development, 
inflammation, proliferation, cell adhesion/ migration and cancer growth [1,2,3]. Tissue factor 
pathway inhibitor (TFPI) is a natural antagonist of TF which inhibits the complex formation of factor 
Xa and TF/factor Ⅶa. Therefore, the effect of TF is regulated by a balance between TF and TFPI. 
We have previously shown that TF and TFPI are expressed by intrinsic kidney cells, such as 
mesangial cells, proximal tubular epithelial cells and human podocytes [4,5,6,7]. In the kidney, TF is 
primarily expressed in the podocytes and parietal epithelial cells of glomeruli [8]. 
Hypoxia contributes to renal damage in acute kidney injury, as well as chronic kidney disease 
(CKD) [9]. However, most studies have focused on tubulointerstitial injury, while little attention has 
been paid to glomerular damage. Recently, Neusser et al showed that hypoxia regulated gene 
expressions were increased in glomeruli from human kidney biopsy specimens from patients with 
hypertensive nephrosclerosis, which is one of the most important causes of CKD. HIF is a key 
transcription factor which regulates adaptive responses to hypoxia. They demonstrated that the HIF 
target gene, chemokine receptor C-X-C motif receptor (CXCR4), was prominently increased in 
podocytes, and HIF-1α showed nuclear localization, which was indicative of HIF activation [10]. 
Ding et al also showed that forced HIF stabilization by deletion of the Von Hippel-Lindau gene 
induced CXCR4 in the glomeruli and resulted in necrotizing crescentic glomerulonephritis [11]. In 
vitro studies as well have been reported hypoxic podocyte injury. It was demonstrated that podocytes 
appeared swollen with narrowed filtration slits [12,13], and the expressions of slit diaphragm proteins, 
such as podocin, CD2-associated protein (CD2AP) and nck were reduced under hypoxic conditions 
[14]. Furthermore, podocytes treated in hypoxia for 48 h developed actin disarrangement [14]. 
In cancer cells, such as glioma, lung cancer, and breast cancer hypoxia induces TF [15,16,17]. On 
the other hand, the expression of TF in podocytes under hypoxic conditions is not known. 
In the present study, we hypothesized that TF is induced in the hypoxic conditions in podocytes and 
contributes to podocyte damage. We investigated the expression of TF and TFPI under hypoxic 
conditions, and further tested its regulatory mechanisms. 
 
. 
 
Materials and methods 
Cell culture and hypoxic conditions 
 
Immortalized human podocytes were maintained in RPMI 1640 containing 10% fetal bovine serum 
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(FBS), 1% insulin-transferrin-selenium-A supplement (Invitrogen, Carlsbad, CA), penicillin (100 
U/mL) and streptomycin (100 μg/mL). Cells were grown at 33℃ in 95% air, 5% CO2 and then were 
converted to differentiated cells by incubating at 37℃ for 10 days. Cells were kept in 1% FBS for 24 
h and then treated under normoxic or hypoxic conditions. The hypoxic condition (an atmosphere of 
1% oxygen) was achieved using an anaerobic chamber equipped with an aerating agent (Anaeropack, 
Mitsubishi Gas Chemical, Tokyo, Japan). For analysis of the regulatory mechanism, podocytes were 
incubated with 100 μM of pyrrolidine dithiocarbamate (PDTC), a nuclear factor kappa B (NF-κB) 
inhibitor. Cells were used between passages 15-18. 
 
Small interfering RNA  
 
Cultured podocytes were transfected using small interfering RNA (siRNA) as described by the 
manufacturer. A siRNA targeted to an irrelevant mRNA served as the non-specific control. Cells were 
transfected with siRNA (100 nM) without antibiotics for 24 h using Dharmafect transfection reagent 
(GE Healthcare), according to the manufacturer’s protocol. Then the cells were further incubated for 
24h under hypoxic or normoxic cinditions. Depletion of target gene was determined by real-time 
polymerase chain reaction (RT-PCR). 
 
Assay of tissue factor and tissue factor pathway inhibitor 
 
The protein levels of TF in the cell lysate and TFPI in the culture supernatant were quantified by 
enzyme-linked immunosorbent assay (ELISA) using Total TF ELISA Kit and IMUBIND Total TFPI 
ELISA Kit (IMUBIND, Sekisui Diagnostics), respectively. These are sandwiched ELISA employing 
murine anti-human TF monoclonal antibody and rabbit anti-human TFPI polyclonal antibody, 
respectively as the capture antibodies. Podocytes were cultured on 6-well plates (Becton Dickinson, 
Oxford, CA). Podocytes were washed twice with Hank’s balanced salt solution (HBSS; Gibco 
Laboratories) and incubated with 1% FBS for 24 h before treatment, then the cells were incubated 
under normoxic or in hypoxic condition for 6 h or 24 h. TF was measured in the cell lysates. The 
cells from each well were disrupted by repeated freeze-thaw cycles with a buffer of 
Tris-buffered-saline (50 mM Tris, 100 mM NaCl), at pH 7.4 and containing 0.1% Triton X-100. 
TFPI was measured in the culture supernatants. After removal of the supernatant, cells were 
dissolved in NaOH and protein content was measured by the method of Lowry et al [18]. The levels 
of TFPI were normalized by the protein content in each well.  
 
 
Analysis of mRNA expressions by quantitative RT-PCR  
 
Total RNA was extracted from the cells using QIA shredder and RNeasy Protect Mini Kit (QIAGEN, 
Valencia, CA). RNA was transcribed into the firststrand cDNA with the Omniscript RT kit 
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(QIAGEN) according to the manufacturer’s description. Quantitative RT-PCR was performed using 
an ABI PRISM 7700 Sequence Detector (Applied Biosystems, Foster City, CA) with TaqMan 
Universal PCR Master Mix (Applied Biosystems). The specific primers and probes (Applied 
Biosystems) were acquired to detect human TF (Assay ID: Hs01076029_m1), human TFPI (Assay 
ID: Hs00196731_m1), CD2AP (CD2-associated protein) (Assay ID: Hs00961451_m1), synaptopodin 
(Assay ID: Hs00702468_s1), human glyceraldehyde-3-phosphatasedehydrogenase (GAPDH) (Assay 
ID: Hs99999905_m1), Egr-1 (Assay ID: Hs00152928_m1), and hypoxia-inducible factor-1α 
(HIF-1α) (Assay ID:Hs00468869_m1). Results were normalized by the expression levels of GAPDH. 
 
Western blot analysis 
 
For nuclear and cytoplasm extraction, NE-PER nuclear and cytoplasmic extraction reagents (Thermo 
Scientific, Rockford, IL) were used according to the instruction. Sample protein content was 
determined by the BCA protein assay (Thermo Scientific). Twenty micrograms of total protein were 
loaded per lane for sodium dodecyl sulfate–polyacrylamide gel electrophoresis (10% wt/vol) analysis 
and transferred to polyvinyliden difluoride membranes. Membranes were incubated with rabbit anti 
phospho- NF-κB p65 and total NF-κB p65 antibody (Cell signaling, Danvers, MA) and visualized by 
using a horseradish peroxidase (HRP) secondary antibody (Santa Cruz Biotechnology). The protein 
bands were detected by Amersham ECL Prime Western Blotting Detection Reagents (GE Healthcare, 
Buckinghamshire, UK). Densitometric analysis was performed with image J software. Blots were 
also analyzed for tubulin for cytoplasmic fraction and lamin A/C for nucleus fraction as a loading 
control. 
 
Immunofluorescence study  
 
Podocytes were grown and differentiated on glass bottom culture dishes (MatTec, Ashland, MA). 
Cells were pretreated in 1% reduced serum for 24 h and incubated under hypoxic or normoxic 
coditions. The cells were fixed with ice-cold methanol for 30 min, permeabilized with 0.1% Triton 
X-100 in phosphate-buffered saline (PBST) for 20 min. The cells were incubated with anti-human TF 
mouse monoclonal antibody (Abnova) or anti-human HIF-1α mouse monoclonal antibody (abcam) 
diluted 1:200 in blocking buffer for 1 h and then incubated with an Alexa-Fluor 488 goat anti mouse 
antibody for 2 h. For the staining of p65, cells were incubated overnight with anti phospho- NF-κB  
rabbit monoclonal antibody (Cell Signaling), diluted 1:100 in blocking buffer and then incubated 
with an Alexa-Fluor 488 goat anti rabbit antibody for 2 h. For F-actin staining, cells were incubated 
after fixation with an Alexa Fluor 488-conjugated phalloidin antibody (Molecular Probes, Carlsbad, 
CA) for 1 h. Samples were covered with antifading mounting medium with or without 
4’,6-diamidino-2-phenylindole (Vector Laboratories, Burlingame, CA). Preparations were image 
using a fluorescence microscope (model BZ-X700; Keyence). 
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Effect of cobalt chloride on tissue factor and tissue factor pathway inhibitor production 
 
To verify the effect of hypoxia, podocytes were treated with cobalt chloride (CoCl2) (75 μM and 150 
μM), which is a strong inducer of HIF activation and mimicry of a hypoxic condition. Podocytes 
were incubated with CoCl2 for 6 h and 24 h; the mRNA expressions of TF and TFPI were then 
examined by quantitative RT-PCR.  
 
Statistical analysis 
 
All data were expressed as mean ± standard deviation (SD). The results were compared using 
Student’s independent samples t-test or one-way analysis of variance (ANOVA) followed Turkey’s 
honestly significant difference test and the two-way repeated-measures ANOVA. P < 0.05 was 
considered to be significant. 
 
Results 
Expression of tissue factor and tissue factor pathway inhibitor mRNA under hypoxic conditions  
 
The time course of TF mRNA expression in podocytes is shown in Figure 1A. The relative TF 
mRNA expression under hypoxic conditions was significantly higher than normoxic conditions both 
at 6 h and 24 h (6 h: 2.29 ± 0.05 fold, p<0.001; 24 h: 5.6 ± 2.4 fold, p<0.05). The time course of TFPI 
mRNA expression in podocytes is shown in Figure 1B. The relative TFPI mRNA expression under 
hypoxic conditions was significantly lower than normoxic conditions both at 6 h and 24 h (6 h: 0.54 
± 0.04 fold, p<0.05; 24 h: 0.24 ± 0.06 fold, p<0.001). 
 
Expression of tissue factor and tissue factor pathway inhibitor mRNA after treatment with cobalt 
chloride 
 
As shown in Figure 2A, the expression of TF significantly increased after treatment with CoCl2 
which mimics hypoxia. CoCl2 suppressed the expression of TFPI mRNA (Figure 2B) 
 
 
Expression of tissue factor and tissue factor pathway inhibitor under hypoxic conditions by 
enzyme-linked immunosorbent assay  
 
Hypoxia increased the expression of TF in the cell lysate (6 h: 1152.8 ± 125.7 pg/mL protein in the 
controls and 1561.7 ± 12.6 pg/mL protein in the hypoxia-stimulated cells, p=0.08; 24 h: 1032.5 ± 
67.18 pg/mL protein in the controls and 2845.1 ± 618.1 pg/mL protein in the hypoxia-stimulated cells, 
p<0.05; 36 h: 1556 ± 158.2 pg/mL protein in the controls and 3447.9 ± 137.9 pg/mL protein in the 
hypoxia-stimulated cells, p<0.05 ) (Figure 3A). Hypoxia suppressed TFPI in the supernatant (6 h: 
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1.18 ± 0.5 ng/mL protein in the controls and 0.25 ± 0.1 ng/mL protein in the hypoxia-stimulated cells , 
p<0.05; 24 h: 1.88 ± 0.72 ng/mL protein in the controls and 0.3 ± 0.13 ng/mL protein in the 
hypoxia-stimulated cells, p<0.05, 36 h: 1.18 ± 0.11 ng/mL protein in the controls and 0.64 ± 0.07 
ng/mL protein in the hypoxia-stimulated cells, p<0.05) (Figure 3B). 
  
 
Immunofluorescence study  
 
In the immunofluorescent study, the enhancement of TF staining was observed in the cytoplasm of 
podocyte exposed to hypoxia for 6 h (Figure 4B) compared with normoxia (Figure 4A). HIF-1 was 
also strongly stained in the cell nuclei of podocytes exposed to hypoxia for 6 h (Figure 4D) compared 
with normoxia (Figure 4C). 
 
Effect of hypoxia-inducible factor-1α small interfering RNA 
The mRNA levels of HIF-1α were reduced by transfection with siRNA, suggesting that the 
knockdown of target gene was achieved by RNA interference (Figure 5A). The results showed that 
HIF-1α siRNA further increased the expression of TF mRNA under hypoxic conditions (Figure 5B). 
On the other hand, decreased expression of TFPI mRNA by hypoxic condition was significantly 
recovered by HIF-1 siRNA (Figure 5C). 
 
Effect of early growth response protein 1 small interfering RNA 
 
To determine whether siRNA targeted against Egr-1 altered the expression of TF, podocytes were 
transfected with Egr1 siRNA for 24 h. The mRNA expression of Egr-1 was successfully reduced by 
transfection with siRNA (Figure 6A). However, Egr-1 siRNA did not have an influence on the 
expressions of TF and TFPI (Figures 6B and 6C). 
 
Tissue factor induction by hypoxia was attenuated by nuclear factor kappa B inhibition 
 
To evaluate the activation of NF-κB in the podocytes, cells were incubated under normoxia or 
hypoxia for 1 h. The expression of phosphorylated NF-κB p65 was enhanced in the nucleus (Figure 
7B) compared with normoxia (Figure 7A), documenting the activation of NF-κB. The expression of 
phosphorylated p65 was increased in the nucleus. The amount of phosphorylated p65 in the 
cytoplasm as well was significantly increased, on the other hand, total amount of p65 in the 
cytoplasm was not altered (Figure 7C and D). Furthermore, the NF-κB inhibitor PDTC significantly 
reduced the expression of TF in hypoxia (Figure 7E), showing that TF upregulation in podocytes was 
dependent on NF-κB activation. On the other hand, the expression of TFPI mRNA tend to recover 
but there was no significant difference (Figure 7F).  
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Temporary knockdown of tissue factor attenuates hypoxia induced podocyte injury  
 
To access the role of TF in podocyte damage, the expression of slit diaphragm molecules CD2AP 
and synaptopodin in podocytes were evaluated by quantitative RT-PCR. The expression of CD2AP 
mRNA was significantly decreased by 24h incubation in hypoxia, and it was significantly recovered 
by TF siRNA (Figure8A). On the other hand, the expression of synaptopodin mRNA was 
significantly decreased by 24h incubation in hypoxia, but there was not a significant change by TF 
siRNA (data not shown). 
In addition, podocytes undergo actin reorganization in response to hypoxia. By phalloidin staining, 
untreated differentiated podocytes demonstrated the characteristic central stress fibers of actin 
(Figure 8B) which are disrupted by hypoxia, resulting in actin reorganization (Figure 8C). A 
temporary knockdown of TF by siRNA prevented actin reorganization (Figure 8G). Cells transfected 
with control siRNA showed actin reorganization in response to hypoxia (Figure 8E). Under normoxia, 
the cells transfected with control siRNA (Figure 8D) and TF siRNA (Figure 8F) showed the 
characteristic central stress fibers. (Data are representative one of three independent experiments). 
 
Discussion 
 
In the present study, we showed that hypoxia increased the expression of TF and decreased the 
expression of TFPI in differentiated human podocytes in culture.  
According to previous knowledge in other cell types [19], we tested the roles of Egr-1 and NF-κB as 
candidate transcription factors for the regulation of TF. Also, we tested the role of HIF, which is a key 
transcription factor in hypoxia. As a result, temporary knockdown of Egr-1 by siRNA did not affect 
the expression levels of TF. NF-κB is an important rapid-acting transcription factor found in all cell 
types and is involved in cellular responses to stimuli, such as stress, hypoxia, cytokines, and 
infections.  
In podocytes, hypoxia increased the expression of phosphorylated NF-κB p65 in the nucleus 
compared with normoxia, which signified NF-κB activation. PDTC, an inhibitor of NF-κB, partially 
suppressed TF expression induced by hypoxia.  
As expected, HIF-1α expression in the cell nuclei was increased by hypoxic conditions in podocytes, 
showing HIF-1α activation. Interestingly, temporary knockdown of HIF-1α by siRNA further 
increased the hypoxia induced TF expression, thus, HIF-1α may act to prevent excessive expression 
of TF in the podocytes.  
We confirmed that hypoxia for 24 h decreased the expression of slit diaphragm protein CD2AP and 
synaptopodin in podocytes, and the expression of CD2AP was significantly recovered by temporary 
knockdown of TF by siRNA, and TF siRNA did not change the expressions of synaptopodin. These 
results were compatible with the previous report that the alteration of CD2AP was greater than that of 
synaptopodin [14]. In addition, hypoxia for 24 h induced the reorganization of actin cytoskeleton in 
9 
 
podocytes, which may correspond to changes in foot process effacement. Temporary knockdown of 
TF also attenuated hypoxia induced actin reorganization at least in part. Thus, we showed here for the 
first time, that TF plays a significant role in hypoxic podocyte injury. Some previous works in other 
cell types suggest a relationship between TF and actin cytoskeleton. The interaction of the 
cytoplasmic domain of TF with the cytoskeleton [20,21], as well as that of TF with α3β1-integrin 
which is involved in the adhesion of the sole of podocyte foot processes to laminin-5 in the 
glomerular basement membrane (GBM), have been demonstrated [22]. In addition, studies on 
cultured cancer cells revealed that interaction between the cytoplasmic domain of TF and 
actin-binding protein (ABP-280) induced cytoskeletal rearrangement. Therefore, it is reasonable to 
infer that TF may play a critical role in the maintenance of the actin cytoskeleton in podocytes. 
On the contrary, mice lacking the cytoplasmic domain of TF caused albuminuria, podocyte 
effacement and reduced podocyte number [1]. These results suggest that either excess or reduced TF 
function may lead to podocyte injury.  
Proteinuria is an independent risk factor for end-stage renal disease regardless of the underlying 
pathology [23]. It has been reported that the risks of mortality, myocardial infarction, and progression 
to kidney failure for a given level of eGFR were independently increased in patients with higher 
levels of proteinuria [24].  
Thus, podocyte injury which is a critical cause of proteinuria, is an important clinical problem. 
Podocyte injury is difficult to recognize in regular light microscopy analysis, therefore, 
hypoxia-induced podocyte injury may have been underestimated, compared with tubulointerstitial 
injury. Our results suggested that podocyte injury under hypoxic conditions deserves more attention 
in further studies. 
Fibrin depositions within the glomeruli are commonly seen in kidney biopsy specimens. It is 
reasonable that the activation of intraglomerular coagulation is related to the rupture of capillary loop. 
However, the results of the present study suggests that upregulation of TF in the podocyte may not 
need the disruption of capillary loop.  
There are some limitations in this study. This is an in vitro study, and it is not known how hypoxia 
acts on podocytes in vivo. Besides, it is not clear how important is the local expression of TF in 
podocytes compared with systemic TF levels in the blood. Phalloidin staining is a generally accepted 
methods to access podocyte injury, however, it is a visual determination which lacks in objectivity 
and quantativity. Our results warrant the importance of further studies on TF in the podocytes. 
In summary, we showed that hypoxia increased the expression of TF in differentiated human 
podocytes in culture. It was dependent on NF-κB, whereas HIF-1α negatively regulated these 
changes. In addition, hypoxia induced podocyte injury which was attenuated by temporary 
knockdown of TF, showing that TF may play a significant role in podocytes. 
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Legend to figures 
 
Figure1 
Human podocytes were incubated in normoxic or hypoxic conditions for 6h and 24h. Hypoxia significantly 
increased mRNA expression levels of TF (A) and TFPI (B). (n=3: *P<0.05 v.s. normoxia, **P < 0.001 v.s. 
normoxia). 
 
Figure2 
Human podocytes were incubated with 75 μM and 150 μM of Cobalt Chloride (CoCl2) for 6 h and 24 h. CoCl2 
significantly increased mRNA expression levels of TF (A) and significantly decreased mRNA expression levels of 
TFPI (B) (n=3: *P<0.05 v.s. control). 
 
Figure3 
Human podocytes were incubated in normoxic or hypoxic conditions for 6 h, 24h and 36 h. Hypoxia (square 
circles) significantly increased protein levels of TF in the cell lysate compared with normoxia (open circles) (n=4: 
*P<0.05 vs normoxia) (A). Hypoxia (square circles) significantly decreased protein levels of TFPI in the cell 
supernatant compared with normoxia (open circles) (n=4: *P<0.05 v.s. normoxia) (B).  
 
Figure4 
Immunofluorescent study. Human podocytes were incubated in normoxic or hypoxic conditions for 6 h. In hypoxia, 
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TF staining was enhanced in the cytoplasm (B) in comparison with normoxia (A). Hypoxia enhanced hypoxia 
inducible factor-1α (HIF-1α) expression in the cell nuclei (D) (nuclei stained with 4’,6-diamidino-2-phenylindole 
and shown in blue in the right column) in comparison with normoxia (C). (Data are representative one of three 
independent experiments). 
 
Figure5 
The expression of HIF-1α mRNA was effectively suppressed by siRNA in human podocytes (A). Temporary 
knockdown of HIF-1α expression by siRNA further increased the expression of TF (B). Whereas, mRNA 
expression of TFPI returned to baseline (C). (n=3: *P < 0.05 v.s. control siRNA, **P < 0.001 v.s. control siRNA). 
 
Figure6 
The expression of Egr1 mRNA was effectively suppressed by siRNA in human podocytes (A). Temporary 
knockdown of Egr1 expression by siRNA did not alter the expression of TF (B), and TFPI (C). (n=3: *P < 0.05 v.s. 
control siRNA).  
 
Figure7 
Human podocytes were incubated in normoxic or hypoxic conditions for 1h. In normoxia, the expression of 
phosphorylated p65 is weak as noted by the light red fluorescence in the left column (A) (nuclei stained with 
4’,6-diamidino-2-phenylindole and shown in blue in the right column). In hypoxia, the expression of 
phosphorylated p65 was enhanced in the nucleus (B). (Data are representative one of three independent 
experiments). Western blotting analysis demonstrated that phosphorylated p65 was increased in the nucleus in 
hypoxic condition. The amount of phosphorylated p65 in the cytoplasm as well was significantly increased, on the 
other hand, total amount of total p65 in the cytoplasm was not altered (C) and (D). (n =3: *P < 0.05). Then, human 
podocytes were incubated in normoxic or hypoxic conditions for 24 h with or without NF-κB inhibitor PDTC (100 
μM). PDTC significantly reduced the expression of TF both at basal level and in response to hypoxia (E). TFPI 
mRNA was not significantly changed by PDTC (F). (n=3: *P < 0.05 v.s. control).  
 
Figure8 
The expression of CD2AP mRNA was significantly decreased by 24h incubation in hypoxia, and it was 
significantly recovered by TF siRNA (A) (n=3: *P < 0.05 v.s. control siRNA). Podocytes undergo actin 
reorganization in response to hypoxia. By phalloidin staining, untreated differentiated podocytes demonstrate 
characteristic central stress fibers of actin (B) which are disrupted by hypoxia, resulting in actin reorganization (C). 
Temporary knockdown of TF by siRNA prevented actin reorganization (G). Cells transfected with control siRNA 
show actin reorganization in response to hypoxia (E). In normoxia, the cells transfected with control siRNA (D) and 
TF siRNA (F) showed characteristic central stress fibers. (Data are representative one of three independent 
experiments). 
 
